Safety of Modified Dust Mite Subcutaneous Immunotherapy in Severe Allergic Asthma

被引:0
|
作者
Gonzalez, Ruperto [1 ]
Poza, Paloma [2 ]
Matheu, Victor [3 ]
Sanchez-Machin, Inmaculada [4 ]
机构
[1] Hosp Ofra Torax, Santa Cruz de Tenerife, Spain
[2] Hosp Ofra Torax, Santa Cruz De Tenerife, Spain
[3] Hosp Ofra, Tenerife, Spain
[4] Hosp Ofra Torax, Tenerife, Spain
关键词
D O I
10.1016/j.jaci.2012.12.1400
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB205 / AB205
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma
    Zhang, Panpan
    Jia, Yuanyuan
    Jing, Zenghui
    Huang, Jinli
    Wu, Huajie
    Sun, Xin
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 78
  • [2] Safety in immunotherapy with dust mite allergens in asthma and allergic rhinitis
    Celio Murillo, R.
    Laurrabaquio Miranda, A. M.
    Abou Kahir, F.
    Tinoco Moran, I. O.
    Rodriguez Santos, O.
    Cuevas Castillejos, H. U.
    Cruz Suarez, M. A.
    ALLERGY, 2013, 68 : 585 - 585
  • [3] House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis
    Feng, Mulin
    Zeng, Xiaohui
    Li, Jing
    JOURNAL OF THORACIC DISEASE, 2019, 11 (08) : 3616 - 3625
  • [4] Efficacy and safety of 2-year subcutaneous immunotherapy with house dust mite extract for allergic rhinitis and asthma
    Tu, Y.
    Shi, L.
    Zhi, L.
    Zhao, L.
    Jin, P.
    Zi, X.
    Li, A.
    Jin, Y.
    ALLERGY, 2016, 71 : 336 - 336
  • [5] Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis
    Valero, Antonio
    Ibanez-Echevarria, Ethel
    Vidal, Carmen
    Raducan, Isabela
    Castello Carrascosa, Jose Vicente
    Sanchez-Lopez, Jaime
    IMMUNOTHERAPY, 2022, 14 (09) : 683 - 694
  • [6] Clinical efficacy and safety of combined house dust mite subcutaneous immunotherapy and omalizumab in five cases of allergic rhinitis and asthma
    Kathuria, P. C.
    Rai, Manisha
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2021, 12 (03) : 175 - 178
  • [7] Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
    Yaqi Yang
    Dongxia Ma
    Nan Huang
    Wenjing Li
    Qing Jiang
    Yin Wang
    Xiaolong Wang
    Lin Yang
    Rongfei Zhu
    Italian Journal of Pediatrics, 47
  • [8] Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
    Yang, Yaqi
    Ma, Dongxia
    Huang, Nan
    Li, Wenjing
    Jiang, Qing
    Wang, Yin
    Wang, Xiaolong
    Yang, Lin
    Zhu, Rongfei
    ITALIAN JOURNAL OF PEDIATRICS, 2021, 47 (01)
  • [9] Efficacy and safety of subcutaneous immunotherapy combined with omalizumab in children with dust mite-induced asthma
    Long, Chao
    Sun, Caihong
    Lin, Hang
    Gao, Xiang
    Qu, Zhenghai
    JOURNAL OF ASTHMA, 2024,
  • [10] Allergic Rhinitis in Remission after House Dust Mite Subcutaneous Immunotherapy
    Harintajinda, Supamas
    Kiewngam, Potjanee
    Jotikasthira, Wanlapa
    Sawatchai, Adithep
    Klangkalya, Natchanun
    Kanchongkittiphon, Watcharoot
    Manuyakorn, Wiparat
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB47 - AB47